Back to Search Start Over

Influence of pH modifiers on the dissolution and stability of hydrochlorothiazide in the bi- and three-layer tablets

Authors :
SANDRA UREK BLATNIK
ROK DREU
STANKO SRČIČ
SANDRA UREK BLATNIK
ROK DREU
STANKO SRČIČ
Source :
Acta Pharmaceutica; ISSN 1330-0075 (Print); ISSN 1846-9558 (Online); Volume 65; Issue 4
Publication Year :
2015

Abstract

During the past few years, the studies of bi- and multi-layered tablets increased due to the consumption of several different drugs per day by a patient and requests for appropriate patient compliance. The demographic shift toward older population increases the use of combination therapy as polypharmacy. Hydrochlorothiazide (HCTZ), as a model drug, is most commonly used in the treatment of hypertension, congestive heart failure and as a diuretic. The aim of the present study is to investigate the effect of the local environment on dissolution and stability behaviour of HCTZ in fixed multi-layered tablet combinations, which are commonly used in polypharmacy. For this purpose, three different systems were introduced: (i) two conventional tablets (HCTZ and pH modifying placebo), (ii) 2-layer tablets (HCTZ, pH modifying placebo) and (iii) 3-layer tablets (HCTZ, barrier and pH modifying placebo). Disintegration of tablets, dissolution of HCTZ from tablets and HCTZ related substances were monitored for all systems. Results showed that there was a significant difference between dissolution profiles of the conventional two-tablet system (HCTZ tablet and pH modifying tablet) and the 2-layer and 3-layer tablets, which include the pH modifying layer. In the case of the conventional two-tablet system, 85 % of HCTZ was dissolved in less than 15 minutes. The dissolution profiles of HCTZ from 2-layered and 3-layered tablets showed a decrease in the dissolution rate. In addition, during the stability studies, it has been confirmed that the typical degradation product of HCTZ is formed, impurity B (4-amino-6-chloro-1,3-benzenedisulfonamide), which implies formation of formaldehyde as hydrolytic impurity not reported in the Ph. Eur. (16). Both impurities are particularly raised in 2-layered tablets with alkaline and neutral placebo layers. Stability of HCTZ was improved in the case of the 3-layer tablet, where the intermediate separation layer of glycerol monostearate was present. It

Details

Database :
OAIster
Journal :
Acta Pharmaceutica; ISSN 1330-0075 (Print); ISSN 1846-9558 (Online); Volume 65; Issue 4
Notes :
application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn937342902
Document Type :
Electronic Resource